Skip to main content
    H

    Harrow Health Inc (HROW)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $29.09
    -1.03 (-3.42%)

    Market Cap: $1.13B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Harrow Health Inc (HROW) Financials: Revenue, Profit and Cash Flow

    Updated Nov 9, 2026. Financial statements from company filings, amounts in US dollars.

    Harrow Health reported revenue of $272.30M for the fiscal year ended Dec 31, 2025, up 36.4% from the year before. That year, net income was -$5.14M with a net margin of -1.9%, operating cash flow was $43.86M and free cash flow was $42.98M. The quarter ended Sep 30, 2026 had revenue of $99.30M and net income of $9.76M.

    Revenue and Margins

    The operating margin was 11.2% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $19.94M, a compound annual rate of 33.7%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$272.30M+36.4%75.1%11.2%-1.9%
    Dec 2024$199.61M+53.3%75.3%4.4%-8.8%
    Dec 2023$130.19M+47.0%69.6%0.3%-18.7%
    Dec 2022$88.59M+22.2%71.3%2.2%-15.9%
    Dec 2021$72.48M+48.3%74.9%2.2%-24.8%
    Dec 2020$48.87M-4.5%70.4%0.8%-7.0%
    Dec 2019$51.16M+23.7%67.3%-9.4%-0.2%
    Dec 2018$41.37M+54.5%60.1%-12.6%35.3%
    Dec 2017$26.77M+34.3%49.6%-45.4%-44.8%
    Dec 2016$19.94MN/A50.7%-79.6%-95.7%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income rose 856.9% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$272.30M$199.61M$130.19M$88.59M$72.48M$48.87M$51.16M$41.37M$26.77M$19.94M
    Cost of revenue$67.93M$49.24M$39.64M$25.38M$18.21M$14.46M$16.75M$16.52M$13.51M$9.83M
    Gross profit$204.37M$150.37M$90.55M$63.21M$54.26M$34.41M$34.42M$24.85M$13.27M$10.11M
    Research and development$20.94M$12.23M$6.65M$3.05M$11.08M$2.41M$2.08M$825.00K$413.00K$739.00K
    Operating income$30.52M$8.82M$431.00K$1.92M$1.61M$385.00K-$4.79M-$5.22M-$12.16M-$15.88M
    Net income-$5.14M-$17.48M-$24.41M-$14.09M-$18.01M-$3.42M-$125.00K$14.63M-$11.98M-$19.09M
    EBITDA$53.52M$26.48M$15.70MN/AN/AN/A-$990.00K-$3.05M-$10.66M-$12.08M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$99.30M$70.66M$44.20M$89.09M$71.64M$63.74M$47.83M$66.83M$49.26M$48.94M$34.59M$36.35M
    Gross profit$74.90M$50.36M$27.05M$70.62M$53.93M$47.51M$32.31M$52.70M$37.24M$36.40M$24.03M$25.05M
    Operating income$11.47M-$11.01M-$22.08M$15.59M$14.75M$11.41M-$11.23M$12.90M$1.32M$1.53M-$6.93M-$4.88M
    Net income$9.76M-$17.27M-$27.60M$6.63M$1.02M$5.00M-$17.78M$6.78M-$4.22M-$6.47M-$13.56M-$9.15M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $244.07M exceeded cash and equivalents by $171.14M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$399.48M$388.97M$312.16M$157.38M$98.33M$57.47M$59.09M$49.45M$23.92M$27.25M
    Current assets$211.75M$189.65M$139.48M$118.26M$60.66M$40.98M$36.05M$32.84M$8.81M$14.75M
    Cash and equivalents$72.93M$47.25M$74.08M$96.27M$42.17M$4.10M$4.75M$6.64M$4.02M$8.85M
    Total liabilities$347.39M$319.67M$241.75M$130.14M$87.40M$30.65M$31.67M$24.70M$21.30M$20.82M
    Short-term debt$887.00K$497.00K$806.00K$723.00K$280.00K$3.90M$1.77M$2.53M$598.00K$4.43M
    Long-term debt$243.18M$219.54M$185.88M$104.17M$71.65M$12.38M$12.22M$12.00M$14.01M$7.94M
    Shareholder equity$52.45M$69.65M$70.77M$27.59M$11.29M$27.18M$27.71M$24.75M$2.62M$6.43M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$443.02M$416.82M$419.54M$399.48M$363.07M$345.03M$364.16M$388.97M$351.54M$306.63M$295.54M$311.75M
    Total liabilities$414.19M$401.97M$391.19M$347.39M$316.41M$295.73M$308.07M$319.67M$293.92M$248.45M$235.33M$241.75M
    Cash and equivalents$75.34M$83.89M$94.64M$72.93M$74.29M$52.96M$66.73M$47.25M$72.60M$70.97M$68.54M$74.08M
    Shareholder equity$29.19M$15.20M$28.71M$52.45M$47.02M$49.65M$56.45M$69.65M$57.98M$58.53M$60.56M$70.36M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 98.0% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$43.86M-$22.20M$3.84M$1.71M$5.08M-$1.10M$950.00K$687.00K-$8.80M-$11.21M
    Capital expenditures$887.00K$1.59M$1.46M$2.60M$1.79M$862.00K$1.47M$1.77M$772.00K$6.89M
    Free cash flow$42.98M-$23.80M$2.38M-$892.00K$3.30M-$1.96M-$518.00K-$1.08M-$9.57M-$18.10M
    Dividends paidN/AN/AN/A$876.00K$127.00K$0$127.00K$127.00KN/A$4.32M
    Investing cash flow-$5.46M-$33.16M-$152.55M-$1.74M-$18.69M-$981.00K-$1.83M-$2.20M-$961.00K-$7.29M
    Financing cash flow-$12.72M$28.53M$126.53M$54.14M$51.47M$1.43M-$1.01M$4.13M$4.93M$24.67M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$8.62M-$9.76M-$8.99M$8.41M$16.59M-$803.00K$19.67M-$17.78M$2.95M-$2.75M-$4.63M$8.70M
    Capital expenditures$375.00K$491.00K$194.00K$341.00K$210.00K$166.00K$170.00K$555.00K$604.00K$344.00K$92.00K$194.00K
    Free cash flow-$8.99M-$10.25M-$9.19M$8.07M$16.38M-$969.00K$19.50M-$18.33M$2.35M-$3.09M-$4.72M$8.50M
    Last 12 quarters

    Frequently Asked Questions About HROW

    What is Harrow Health's annual revenue?

    Harrow Health reported revenue of $272.30M for the fiscal year ended Dec 31, 2025.

    How fast is Harrow Health's revenue growing?

    Revenue was up 36.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 45.4%.

    Is Harrow Health profitable?

    No. Harrow Health reported net income of -$5.14M for the fiscal year ended Dec 31, 2025, with a net margin of -1.9%.

    How much free cash flow does HROW generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $43.86M minus capital expenditures of $887.00K produced free cash flow of $42.98M.

    How much debt does Harrow Health have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $243.18M, short-term debt of $887.00K and cash and equivalents of $72.93M.